Invesaro

Stocks Comparison

InnovAge vs U S Physical Therapy: revenue, profit, margins and growth compared

InnovAge brought in $989.7M of revenue in fiscal 2026, U S Physical Therapy $781M in fiscal 2025. Revenue changed by +15.9% at InnovAge and +16.3% at U S Physical Therapy on the year before, so U S Physical Therapy grew faster. InnovAge kept -0.3% of its revenue as net profit, U S Physical Therapy 5.1%. Free cash flow was $50.4M at InnovAge and $61M at U S Physical Therapy.

Side by side, latest fiscal year

INNVUSPH
Fiscal year endedFY2026 (June 30, 2026)FY2025 (December 31, 2025)
Revenue$989.7M$781M
Revenue growth+15.9%+16.3%
Net income-$2.5M$39.6M
Net margin-0.3%5.1%
Free cash flow$50.4M$61M
Free cash flow margin5.1%7.8%
Earnings per share (diluted)-$0.02$1.42
Cash$97.9M$35.6M
Debt$48.8M$162.5M
Price to earningsn/a59.8
Market value$1.2B$1.3B
Dividend yieldn/a2.12%
Rank by revenue in sector#145 of 523 · Health care#163 of 523 · Health care

Over the years

Revenue
INNV FY2021: $567.2MINNV FY2021: $637.8MINNV FY2022: $698.6MINNV FY2023: $688.1MINNV FY2024: $763.9MINNV FY2025: $853.7MINNV FY2026: $989.7MUSPH FY2018: $453.9MUSPH FY2019: $482MUSPH FY2020: $423MUSPH FY2021: $495MUSPH FY2022: $553.1MUSPH FY2023: $604.8MUSPH FY2024: $671.3MUSPH FY2025: $781MFY18FY19FY20FY21FY22FY23FY24FY25FY26
INNV $989.7MUSPH $781M
Net income
INNV FY2021: $26.3MINNV FY2021: -$44MINNV FY2022: -$6.5MINNV FY2023: -$40.7MINNV FY2024: -$21.3MINNV FY2025: -$30.3MINNV FY2026: -$2.5MUSPH FY2018: $34.9MUSPH FY2019: $40MUSPH FY2020: $35.2MUSPH FY2021: $40.8MUSPH FY2022: $32.2MUSPH FY2023: $28.2MUSPH FY2024: $31.4MUSPH FY2025: $39.6MFY18FY19FY20FY21FY22FY23FY24FY25FY26
INNV -$2.5MUSPH $39.6M
Net margin
INNV FY2021: 4.6%INNV FY2021: -6.9%INNV FY2022: -0.9%INNV FY2023: -5.9%INNV FY2024: -2.8%INNV FY2025: -3.6%INNV FY2026: -0.3%USPH FY2018: 7.7%USPH FY2019: 8.3%USPH FY2020: 8.3%USPH FY2021: 8.2%USPH FY2022: 5.8%USPH FY2023: 4.7%USPH FY2024: 4.7%USPH FY2025: 5.1%FY18FY19FY20FY21FY22FY23FY24FY25FY26
INNV -0.3%USPH 5.1%
Revenue growth
INNV FY2021: +12.4%INNV FY2022: +9.5%INNV FY2023: -1.5%INNV FY2024: +11.0%INNV FY2025: +11.8%INNV FY2026: +15.9%USPH FY2019: +6.2%USPH FY2020: -12.2%USPH FY2021: +17.0%USPH FY2022: +11.7%USPH FY2023: +9.3%USPH FY2024: +11.0%USPH FY2025: +16.3%FY19FY20FY21FY22FY23FY24FY25FY26
INNV +15.9%USPH +16.3%
Free cash flow
INNV FY2021: $32MINNV FY2021: -$25.1MINNV FY2022: -$10.9MINNV FY2023: -$3.1MINNV FY2024: -$44.8MINNV FY2025: $26.6MINNV FY2026: $50.4MUSPH FY2018: $65.8MUSPH FY2019: $52.3MUSPH FY2020: $92.4MUSPH FY2021: $68.2MUSPH FY2022: $50.3MUSPH FY2023: $72.7MUSPH FY2024: $65.8MUSPH FY2025: $61MFY18FY19FY20FY21FY22FY23FY24FY25FY26
INNV $50.4MUSPH $61M

Fiscal years as each company reports them; the two may end in different months.

Questions about InnovAge and U S Physical Therapy

Which is bigger by revenue, InnovAge or U S Physical Therapy?

InnovAge is bigger by revenue: $989.7M in fiscal 2026, against $781M for U S Physical Therapy in fiscal 2025.

Which keeps more of its revenue as profit, InnovAge or U S Physical Therapy?

InnovAge had a net margin of -0.3% in fiscal 2026; U S Physical Therapy had 5.1% in fiscal 2025.

Which grew revenue faster, InnovAge or U S Physical Therapy?

In their latest fiscal years revenue changed by +15.9% at InnovAge and +16.3% at U S Physical Therapy.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies